Braveheart Bio
$21.04
0
-$0.47-2.19%Monday 21:00
+$0.00+0%00:30After hours
Statistics
Day High
21.79
Day Low
20.51
52W High
32
52W Low
17.86
Volume
260,119
Avg. Volume
480,860
Mkt Cap
1.47B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q2 2026
Next
-2.51
-0.78
0.95
2.69
Expected EPS
-0.438
Actual EPS
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
Show More
CEO
Travis Murdoch
Employees
49
Country
United States
ISIN
US10567X1019
Listings
0 Comments
Share your thoughts
FAQs
What is Braveheart Bio stock price today?▼
The current price of BRVE is $21.04 USD — it has decreased by -2.19% in the past 24 hours. Watch Braveheart Bio stock price performance more closely on the chart.
What is Braveheart Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Braveheart Bio stocks are traded under the ticker BRVE.
What is Braveheart Bio market cap?▼
Today Braveheart Bio has the market capitalization of 1.47B
When is the next Braveheart Bio earnings date?▼
Braveheart Bio is going to release the next earnings report on December 2, 2026.
What were Braveheart Bio earnings last quarter?▼
BRVE earnings for the last quarter are -2.51 USD per share, whereas the estimation was 2.69 USD resulting in a -193.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Braveheart Bio have?▼
As of November 3, 2026, the company has 49 employees.
In which sector is Braveheart Bio located?▼
Braveheart Bio operates in the Health & Wellness sector.
When did Braveheart Bio complete a stock split?▼
Braveheart Bio has not had any recent stock splits.
Where is Braveheart Bio headquartered?▼
Braveheart Bio is headquartered in SAN FRANCISCO, United States.